Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Drug Review Reorganization Boosts Advisory Role Of Medical Imaging Division

Executive Summary

FDA's reorganization of its drug review divisions will allow the Office of New Drugs' medical imaging staff to assume a broader role in consulting on trials that use medical images as an endpoint

You may also be interested in...



Oncology Drug Reviews To Be Restructured As Office Shifts Away From Divisions Organized Around Molecule Size

FDA's Office of Oncology Drug Products is undergoing a reorganization aimed at making its structure more similar to the rest of the review offices in the Center for Drug Evaluation and Research

Oncology Drug Reviews To Be Restructured As Office Shifts Away From Divisions Organized Around Molecule Size

FDA's Office of Oncology Drug Products is undergoing a reorganization aimed at making its structure more similar to the rest of the review offices in the Center for Drug Evaluation and Research

FDA, Imaging Industry Hear Advice On Radiation Safety Improvements

Groups representing radiologists, imaging technicians and physicists are urging industry to offer more tools to protect patients from potential radiation overexposure during medical imaging

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS052111

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel